---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-018121"
form_type: "8-K"
ticker: "RKLB"
cik: "0001819994"
company_name: "Rocket Lab Corp"
filed_at: "2022-09-06T23:59:59+00:00"
generated_at: "2026-06-23T15:40:00.476416+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Rocket Lab appoints Dr. Edward Frank to Board of Directors, expanding to nine members

## Summary
- Board increased from eight to nine directors; Dr. Frank appointed as Class II director with term expiring at 2023 annual meeting.
- Dr. Frank brings 35+ years of tech leadership, including roles at Apple (VP, Mac Hardware), Broadcom (R&D VP), and founding CEO of Epigram.
- Standard non-employee director compensation: initial $360K RSU grant vesting over 3 years and annual $180K RSU grant.
- Dr. Frank qualifies as an independent director under Nasdaq rules; company will enter indemnification agreement.
- No transactions exceeding $120K between Dr. Frank and company; no arrangements for his appointment other than standard terms.

## SEC filing metadata
- accession: 0000950170-22-018121
- form_type: 8-K
- ticker: RKLB
- cik: 0001819994
- company_name: Rocket Lab Corp
- filed_at: 2022-09-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819994/000095017022018121/0000950170-22-018121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819994/000095017022018121/rklb-20220902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-018121
- JSON: https://secwatch.observer/filing/0000950170-22-018121.json
- Plain text: https://secwatch.observer/filing/0000950170-22-018121.txt

## Key facts
- Executive change
  Dr. Edward H. Frank was appointed as Class II Director at Rocket Lab Corp.
  - Action: appointed
  - Role: Class II Director
  source text: On September 2, 2022, the Board appointed Dr. Edward H. Frank as a Class II director to fill the newly-created vacancy on the Board, with an initial term expiring at the Company’s 2023 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1819994/000095017022018121/0000950170-22-018121-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.